News

Digital Health and Discovery Platform (DHDP)

Published on: 03/04/2025

Digital Health and Discovery Platform (DHDP)

The Digital Health and Discovery Platform (DHDP) funds innovative research to accelerate precision medicine for cancer and neurological diseases by enhancing health data sharing, integrating AI into clinical settings, and mentoring future scientists. The Digital Health Innovation Fund supports research leveraging the platform, prioritizing oncology and neurology but open to other health and AI fields, fostering SME collaboration and commercialization potential.

Funding news

Funding Opportunities

The Digital Health and Discovery Platform (DHDP) seeks to improve health outcomes for Canadians by accelerating precision medicine for cancer and neurological diseases such as Alzheimer’s. To attain this goal, the DHDP funds groundbreaking projects that:

  • Breaking barriers to health data sharing to enable innovation across multiple sites
  • Find novel ways to incorporate AI to clinical settings
  • Mentor a new generation of scientists and clinicians able to problem-solve in complex environments

All projects funded by the DHDP undergo a stringent peer-review process. This promotes scientific excellence and ensures funds go to top research projects across Canada. Proposals will also be evaluated by their engagement in the use of AI methods.

Digital Health Innovation Fund

The purpose of this opportunity is to support the development of research programs through their use of the Platform. While the fund prioritizes oncology and neurology research programs, the DHDP is a disease agnostic initiative. Applications focused on other areas of health and AI research where similar data may be available (eg. diabetes, cardiology) will also be considered. By identifying and selecting research initiatives for their compelling science, projects will advance the design and use of the Platform to support meaningful and impactful projects. In parallel, the intention is to stimulate collaboration among small- and medium- sized enterprises (SMEs), while adopting a view toward the commercialization potential of research discoveries.

Learn more and submit your Expression of Interest!

NEWS​

Related News

VUGENE secures 1 million Euros to revolutionize biological research

7 May 2025
VUGENE, a Lithuania-based multi-omics data analysis company, has announced the closing an investment round of €1 million, led by Superhero Capital tog...

AMR EDUCare: Empowering europe’s healthcare professionals to tackle antimicrobial resistance

6 May 2025

Connect, Innovate, and Transform Healthcare at the AHB Symposium 2025

6 May 2025

Shaping the Future of Digital Health: Insights from the Foresight 2030 Study

6 May 2025

MedFIT 2025

6 May 2025

Have your say: Open Public Consultation for the BeWell Skills Strategy (DUPLICATE)

6 May 2025

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *